An estimated 10% to 30% of people who get COVID-19 suffer from lingering symptoms of the disease, or what's known as "long COVID."

Judy Dodd, who lives in New York City, is one of them. She spent nearly a year plagued by headaches, shortness of breath, extreme fatigue and problems with smell, among other symptoms.

She says she worried that this "slog through life" was going to be her new normal.

Everything changed after she got her COVID-19 vaccine.

"I was like a new person, it was the craziest thing ever," says Dodd, referring to how many of her health problems subsided significantly after her second shot.

More consumers will soon be able to test themselves for COVID-19 from the comfort of their own home. On Wednesday, the Food and Drug Administration approved two rapid antigen home tests for use in the U.S.

Americans will soon be able to purchase Abbott's BinaxNOW and Quidel Quickvue tests at drug stores. The two options join a test made by Ellume, which received FDA approval in December, in the market. The two, newly-approved swab tests will be sold at a lower price point.

The BinaxNOW and Quickvue tests are expected to be sold in two-packs for around $15-20; Ellume costs $30.

Over 100 fully vaccinated people contract COVID-19 in Washington state, officials say Over 100 people in Washington state have tested positive for COVID-19 more than two weeks after becoming fully vaccinated against the disease, officials said. ABC News ABC News

Over 100 people in Washington state have tested positive for COVID-19 more than two weeks after becoming fully vaccinated against the disease, officials said.

EXPLAINER: What we know about AstraZeneca blood clot reports LONDON (AP) — German officials have decided to limit the use of AstraZeneca’s coronavirus vaccine in people under 60 after more unusual blood clots were reported in a small number of people who... AP NEWS

LONDON (AP) — German officials have decided to limit the use of AstraZeneca’s coronavirus vaccine in people under 60 after more unusual blood clots were reported in a small number of people who received the shots.

Analysis of Asymptomatic and Presymptomatic Transmission in SARS-CoV-2 Outbreak, Germany, 2020

Catching the coronavirus from people who are asymptomatic, individuals who are infected but never have symptoms, may be exceptionally rare, according to a small but thorough study of 59 people who had the virus and 254 people they interacted with. However, presymptomatic individuals, those who are infected but haven’t yet begun to show symptoms, accounted for 75 percent of confirmed transmission events, researchers report in an April dispatch of Emerging Infectious Disease.

The seven asymptomatic cases did not transmit the virus to any of their contacts. Twenty-two of the 29 transmission events occurred when an infected person who was not yet showing symptoms interacted with people outside of their household. The study underlines the importance of isolation after testing positive, to reduce the chance of transmission even before symptoms start. ...

Nearly 20 percent say they can't afford needed health care: poll A growing number of Americans are indicating they cannot afford health care, according to a new poll released this week. Dominick Mastrangelo TheHill

A growing number of Americans are indicating they cannot afford health care, according to a new poll released this week.